Skip to main content

Policy/Advocacy

As the COVID-19 pandemic continues, a group of addiction and mental health advocacy organizations have formed a coalition to address barriers to accessing FDA-authorized digital therapeutics.
The Foundation for Opioid Response and New York Community Trust are providing $750,000 to Housing Works for a program that aims to improve high-risk populations’ retention and adherence to medications for opioid use disorder.
The Translational Research Training in Addictions for Racial/Ethnic Minorities program at the City College of New York and Columbia University Medical Center has received a $1.67 million grant from NIH to extend the program for five years.
Advocacy group Shatterproof says a pair of bills introduced in the House that would remove the separate waiver required for prescribing buprenorphine and set baseline requirements around preventing addiction and working with patients with OUD should be revisited in light of COVID-19.
A presentation at the Rx Drug Abuse & Heroin Summit emphasized a person-centered mindset for the activities of rapid response teams targeting overdose survivors.
Back to Top